MINIMALLY INVASIVE STEREOTAXIC METHOD FOR THE TREATMENT OF HEMORRHAGIC STROKE: A CLINICAL CASE

2023

Closed access Metadata (CSL-JSON)
DOI 10.54500/2790-1203-2023-2-116-93-97
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

Hemorrhagic stroke ranks second in frequency among fatal strokes. Often intracerebral hemorrhage is localized in the basal ganglia of the brain and the use of open surgical approaches is fraught with the development of various severe complications. This implies the need to use minimally invasive methods of surgical treatment of deep intracerebral hemorrhages. One of these methods is stereotaxic needle biopsy. The authors present a clinical case of hemorrhagic stroke in a patient who received a minimally invasive stereotaxic treatment. The results of treatment and its effectiveness are reflected. Recommendations are given on the methodology of the possibility of its application in clinics of medical organizations of the Republic of Kazakhstan.